Home > Qtrly Results > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Quarterly Results Analysis [Sep2026]

SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Quarterly Results

Consolidated Sep2026
UnAudited
Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Revenues ₹16,199 Cr ₹15,300 Cr ₹14,612 Cr ₹15,521 Cr ₹14,478 Cr ₹13,851 Cr ₹12,959 Cr ₹13,675 Cr
Expenses ₹11,455 Cr ₹10,882 Cr ₹10,658 Cr ₹10,726 Cr ₹9,951 Cr ₹9,550 Cr ₹9,243 Cr ₹9,666 Cr
Operating Income ₹4,744 Cr ₹4,418 Cr ₹3,954 Cr ₹4,795 Cr ₹4,527 Cr ₹4,302 Cr ₹3,716 Cr ₹4,009 Cr
Other Income ₹517 Cr ₹724 Cr ₹459 Cr ₹733 Cr ₹470 Cr ₹464 Cr ₹613 Cr ₹466 Cr
Interest ₹75 Cr ₹100 Cr ₹86 Cr ₹78 Cr ₹100 Cr ₹75 Cr ₹49 Cr ₹52 Cr
Depreciation ₹758 Cr ₹739 Cr ₹775 Cr ₹732 Cr ₹730 Cr ₹701 Cr ₹664 Cr ₹631 Cr
Profit Before Tax ₹3,159 Cr ₹4,099 Cr ₹3,551 Cr ₹4,227 Cr ₹4,168 Cr ₹3,173 Cr ₹3,254 Cr ₹3,476 Cr
Profit After Tax ₹2,002 Cr ₹2,911 Cr ₹2,724 Cr ₹3,401 Cr ₹3,137 Cr ₹2,303 Cr ₹2,161 Cr ₹2,918 Cr
EPS ₹8.29 ₹12.07 ₹11.31 ₹14.04 ₹13.00 ₹9.50 ₹8.96 ₹12.10
Industry Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES 0.5% -2.9% 5%
DIVIS LABORATORIES 5% 7.2% 49.7%
TORRENT PHARMACEUTICALS -0.5% -4.5% 28.9%
CIPLA 2.4% 2.4% -12.9%
DR REDDYS LABORATORIES 2.7% 8.4% 5.1%
MANKIND PHARMA -1.1% -1.2% 3.1%
LUPIN 1.9% -2.2% 4.5%
ZYDUS LIFESCIENCES 6.3% 6.6% 22.7%
AUROBINDO PHARMA 3.2% 1.1% 53.2%

SUN PHARMACEUTICAL INDUSTRIES Quarterly Revenues

Revenues
Q-o-Q

5.87 %

Y-o-Y

11.88 %

Quarters Revenues % Change
Sep2026 ₹16,199 Cr
5.87
Jun2026 ₹15,300 Cr
4.71
Mar2026 ₹14,612 Cr
-5.86
Dec2025 ₹15,521 Cr
7.20
Sep2025 ₹14,478 Cr
4.53
Jun2025 ₹13,851 Cr
6.89
Mar2025 ₹12,959 Cr
-5.24
Dec2024 ₹13,675 Cr -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Operating Profit

Operating Profit
Q-o-Q

7.38 %

Y-o-Y

4.79 %

Quarters Operating Profit % Change
Sep2026 ₹4,744 Cr
7.38
Jun2026 ₹4,418 Cr
11.72
Mar2026 ₹3,954 Cr
-17.53
Dec2025 ₹4,795 Cr
5.91
Sep2025 ₹4,527 Cr
5.24
Jun2025 ₹4,302 Cr
15.76
Mar2025 ₹3,716 Cr
-7.31
Dec2024 ₹4,009 Cr -
Operating Margins
Q-o-Q

1.45 %

Y-o-Y

-6.33 %

Quarters Operating Margin% % Change
Sep2026 29.29%
1.45
Jun2026 28.87%
6.69
Mar2026 27.06%
-12.40
Dec2025 30.89%
-1.22
Sep2025 31.27%
0.68
Jun2025 31.06%
8.30
Mar2025 28.68%
-2.18
Dec2024 29.32% -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-31.24 %

Y-o-Y

-36.20 %

Quarters Profit After Tax % Change
Sep2026 ₹2,002 Cr
-31.24
Jun2026 ₹2,911 Cr
6.87
Mar2026 ₹2,724 Cr
-19.92
Dec2025 ₹3,401 Cr
8.42
Sep2025 ₹3,137 Cr
36.24
Jun2025 ₹2,303 Cr
6.57
Mar2025 ₹2,161 Cr
-25.94
Dec2024 ₹2,918 Cr -
PAT Margins
Q-o-Q

-35.02 %

Y-o-Y

-42.96 %

Quarters PAT Margin(%) % Change
Sep2026 12.36 %
-35.02
Jun2026 19.02 %
2.04
Mar2026 18.64 %
-14.92
Dec2025 21.91 %
1.11
Sep2025 21.67 %
30.39
Jun2025 16.62 %
-0.30
Mar2025 16.67 %
-21.85
Dec2024 21.33 % -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-31.32 %

Y-o-Y

-36.23 %

Quarters EPS % Change
Sep2026 ₹8.29
-31.32
Jun2026 ₹12.07
6.72
Mar2026 ₹11.31
-19.44
Dec2025 ₹14.04
8.00
Sep2025 ₹13
36.84
Jun2025 ₹9.5
6.03
Mar2025 ₹8.96
-25.95
Dec2024 ₹12.1 -

You may also like the below Video Courses